J&J Buys Abbott's Ophthalmics Business For $4bn-Plus

The move to sell Abbott Medical Optics unit comes in the midst of a significant portfolio overhaul by Abbott. The deal will put J&J in the ophthalmic surgery business.

Abbott Laboratories Inc. is unloading its ophthalmic business to Johnson & Johnson for $4.325bn.

The sale of Abbott Medical Optics unit comes as Abbott is overhauling its medtech portfolio. The firm has repeatedly told investors that it is focused on accelerating the growth of...

Key AMO Products
  • Tecnis toric intraocular lens
  • Catalys cataract laser system
  • STAR S4 IR excimer laser system for LASIK
  • WaveScan WaveFront acquisition and diagnostic system for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight